TORONTO, June 14, 2012 /CNW/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that Jim Mullen, Patheon's CEO, will be presenting a company overview at the Wells Fargo Securities Healthcare Conference on June 20, 2012 at 8:00 a.m. eastern time.
An audio webcast of the corporate presentation will be available to investors and interested parties by accessing the company's website at http://ir.patheon.com/events.cfm. This webcast will be archived for 14 days following the live presentation.
Patheon Inc. (TSX: PTI) is a leading global provider of contract development and manufacturing services to the global pharmaceutical industry. The company provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. Its services range from preclinical development through commercial manufacturing of a full array of dosage forms including parenteral, soft gel, solid and liquid forms.
The company's comprehensive range of fully integrated Pharmaceutical Development Services includes pre-formulation, formulation, analytical development, clinical manufacturing, scale-up and commercialization. The company's integrated development and manufacturing network of 10 manufacturing facilities, nine development centers and one clinical trial material packaging facility across North America and Europe, enables customer products to be launched with confidence anywhere in the world.
For further information:
Investor Relations and Corporate Communications
Tel: (919) 226-3313
Email: [email protected]